FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162945478> ?p ?o ?g. }

• W2162945478 abstract "Abstract Background The traditional smallpox vaccine, administered by scarification, was discontinued in the general population from 1980, because of the absence of new smallpox cases. However, the development of an effective prophylactic vaccine against smallpox is still necessary, to protect from the threat of deliberate release of the variola virus for bioterrorism and from new zoonotic infections, and to improve the safety of the traditional vaccine. Preventive vaccination still remains the most effective control and new vectors have been developed to generate recombinant vaccines against smallpox that induce the same immunogenicity as the traditional one. As protective antibodies are mainly directed against the surface proteins of the two infectious forms of vaccinia, the intracellular mature virions and the extracellular virions, combined proteins from these viral forms can be used to better elicit a complete and protective immunity. Methods Four novel viral recombinants were constructed based on the fowlpox genetic background, which independently express the vaccinia virus L1 and A27 proteins present on the mature virions, and the A33 and B5 proteins present on the extracellular virions. The correct expression of the transgenes was determined by RT-PCR, Western blotting, and immunofluorescence. Results and conclusions Using immunoprecipitation and Western blotting, the ability of the proteins expressed by the four novel FP L1R , FP A27L , FP A33R and FP B5R recombinants to be recognized by VV-specific hyperimmune mouse sera was demonstrated. By neutralisation assays, recombinant virus particles released by infected chick embryo fibroblasts were shown not be recognised by hyperimmune sera. This thus demonstrates that the L1R, A27L, A33R and B5R gene products are not inserted into the new viral progeny. Fowlpox virus replicates only in avian species, but it is permissive for entry and transgene expression in mammalian cells, while being immunologically non–cross-reactive with vaccinia virus. These recombinants might therefore represent safer and more promising immunogens that can circumvent neutralisation by vector-generated immunity in smallpox-vaccine-experienced humans." @default.
• W2162945478 created "2016-06-24" @default.
• W2162945478 creator A5045597232 @default.
• W2162945478 creator A5056033527 @default.
• W2162945478 creator A5057849882 @default.
• W2162945478 creator A5058599191 @default.
• W2162945478 creator A5060230184 @default.
• W2162945478 creator A5086340765 @default.
• W2162945478 date "2013-04-11" @default.
• W2162945478 modified "2023-10-09" @default.
• W2162945478 title "L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines" @default.
• W2162945478 cites W1501948095 @default.
• W2162945478 cites W1568871047 @default.
• W2162945478 cites W1616035554 @default.
• W2162945478 cites W1905216348 @default.
• W2162945478 cites W1969907749 @default.
• W2162945478 cites W1972440007 @default.
• W2162945478 cites W1975646238 @default.
• W2162945478 cites W1981826178 @default.
• W2162945478 cites W1984263551 @default.
• W2162945478 cites W1987052416 @default.
• W2162945478 cites W1990626907 @default.
• W2162945478 cites W1998836839 @default.
• W2162945478 cites W2011145289 @default.
• W2162945478 cites W2011732718 @default.
• W2162945478 cites W2012166818 @default.
• W2162945478 cites W2016862812 @default.
• W2162945478 cites W2019900764 @default.
• W2162945478 cites W2020396775 @default.
• W2162945478 cites W2021318400 @default.
• W2162945478 cites W2021955343 @default.
• W2162945478 cites W2023550663 @default.
• W2162945478 cites W2027765075 @default.
• W2162945478 cites W2029006292 @default.
• W2162945478 cites W2033316562 @default.
• W2162945478 cites W2043889392 @default.
• W2162945478 cites W2046130821 @default.
• W2162945478 cites W2050838541 @default.
• W2162945478 cites W2056529532 @default.
• W2162945478 cites W2064879261 @default.
• W2162945478 cites W2065102092 @default.
• W2162945478 cites W2066270667 @default.
• W2162945478 cites W2077650350 @default.
• W2162945478 cites W2077820971 @default.
• W2162945478 cites W2093243258 @default.
• W2162945478 cites W2094621652 @default.
• W2162945478 cites W2094896122 @default.
• W2162945478 cites W2097225513 @default.
• W2162945478 cites W2107487491 @default.
• W2162945478 cites W2123871872 @default.
• W2162945478 cites W2134161715 @default.
• W2162945478 cites W2143333377 @default.
• W2162945478 cites W2148045713 @default.
• W2162945478 cites W2155803546 @default.
• W2162945478 cites W2158437004 @default.
• W2162945478 cites W2160885488 @default.
• W2162945478 cites W2168127024 @default.
• W2162945478 cites W2184646877 @default.
• W2162945478 cites W4247460913 @default.
• W2162945478 doi "https://doi.org/10.1186/1479-5876-11-95" @default.
• W2162945478 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3637622" @default.
• W2162945478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23578094" @default.
• W2162945478 hasPublicationYear "2013" @default.
• W2162945478 type Work @default.
• W2162945478 sameAs 2162945478 @default.
• W2162945478 citedByCount "18" @default.
• W2162945478 countsByYear W21629454782013 @default.
• W2162945478 countsByYear W21629454782015 @default.
• W2162945478 countsByYear W21629454782016 @default.
• W2162945478 countsByYear W21629454782017 @default.
• W2162945478 countsByYear W21629454782018 @default.
• W2162945478 countsByYear W21629454782019 @default.
• W2162945478 countsByYear W21629454782022 @default.
• W2162945478 countsByYear W21629454782023 @default.
• W2162945478 crossrefType "journal-article" @default.
• W2162945478 hasAuthorship W2162945478A5045597232 @default.
• W2162945478 hasAuthorship W2162945478A5056033527 @default.
• W2162945478 hasAuthorship W2162945478A5057849882 @default.
• W2162945478 hasAuthorship W2162945478A5058599191 @default.
• W2162945478 hasAuthorship W2162945478A5060230184 @default.
• W2162945478 hasAuthorship W2162945478A5086340765 @default.
• W2162945478 hasBestOaLocation W21629454781 @default.
• W2162945478 hasConcept C104317684 @default.
• W2162945478 hasConcept C159047783 @default.
• W2162945478 hasConcept C159654299 @default.
• W2162945478 hasConcept C203014093 @default.
• W2162945478 hasConcept C2522874641 @default.
• W2162945478 hasConcept C2777760223 @default.
• W2162945478 hasConcept C2779094796 @default.
• W2162945478 hasConcept C2779272165 @default.
• W2162945478 hasConcept C2779827044 @default.
• W2162945478 hasConcept C2780868878 @default.
• W2162945478 hasConcept C2781356689 @default.
• W2162945478 hasConcept C2908589346 @default.
• W2162945478 hasConcept C2909788366 @default.
• W2162945478 hasConcept C2910443307 @default.
• W2162945478 hasConcept C39060996 @default.
• W2162945478 hasConcept C40767141 @default.
• W2162945478 hasConcept C54355233 @default.
• W2162945478 hasConcept C86803240 @default.

• next